Log in to save to my catalogue

F]-FDG-PET/CT Correlates With the Response of Radiorefractory Thyroid Cancer to Lenvatinib and Patie...

F]-FDG-PET/CT Correlates With the Response of Radiorefractory Thyroid Cancer to Lenvatinib and Patie...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A702372952

F]-FDG-PET/CT Correlates With the Response of Radiorefractory Thyroid Cancer to Lenvatinib and Patient Survival

About this item

Full title

F]-FDG-PET/CT Correlates With the Response of Radiorefractory Thyroid Cancer to Lenvatinib and Patient Survival

Publisher

Oxford University Press

Journal title

The journal of clinical endocrinology and metabolism, 2021-08, Vol.106 (8), p.2355

Language

English

Formats

Publication information

Publisher

Oxford University Press

More information

Scope and Contents

Contents

Context: (18) F-fluoro-2-deoxy-D-glucose positron emission tomography-computed tomography ([[.sup.18]F]-FDG-PET/CT)-positive metastatic lesions in radioiodine-refractory differentiated thyroid cancer (RAI-R DTC) have a poor prognosis and lenvatinib represents the best therapy. Objective: We investigated the role of [[.sup.18]F]-FDG-PET/CT in the ev...

Alternative Titles

Full title

F]-FDG-PET/CT Correlates With the Response of Radiorefractory Thyroid Cancer to Lenvatinib and Patient Survival

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_infotracmisc_A702372952

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A702372952

Other Identifiers

ISSN

0021-972X

DOI

10.1210/clinem/dgab278

How to access this item